BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 140,400 shares, an increase of 38.2% from the October 15th total of 101,600 shares. Approximately 1.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 376,900 shares, the days-to-cover ratio is currently 0.4 days.
BioNexus Gene Lab Stock Down 6.3 %
NASDAQ BGLC traded down $0.02 during trading on Friday, hitting $0.30. 58,573 shares of the company’s stock were exchanged, compared to its average volume of 605,466. The stock’s 50 day moving average price is $0.39 and its two-hundred day moving average price is $0.46. BioNexus Gene Lab has a fifty-two week low of $0.28 and a fifty-two week high of $3.39.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported $0.01 EPS for the quarter. BioNexus Gene Lab had a negative net margin of 24.01% and a negative return on equity of 23.07%. The business had revenue of $1.98 million during the quarter.
Institutional Inflows and Outflows
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Recommended Stories
- Five stocks we like better than BioNexus Gene Lab
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Warren Buffett Stocks to Buy Now
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Effectively Use the MarketBeat Ratings Screener
- Time to Load Up on Home Builders?
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.